➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Express Scripts
Merck
Dow
Boehringer Ingelheim

Last Updated: July 8, 2020

DrugPatentWatch Database Preview

GLOPERBA Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Gloperba patents expire, and what generic alternatives are available?

Gloperba is a drug marketed by Avion Pharms and is included in one NDA. There are two patents protecting this drug.

This drug has three patent family members in two countries.

The generic ingredient in GLOPERBA is colchicine. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the colchicine profile page.

US ANDA Litigation and Generic Entry Outlook for Gloperba

A generic version of GLOPERBA was approved as colchicine by AMNEAL PHARMS on September 28th, 2016.

  Start Trial

Summary for GLOPERBA
International Patents:3
US Patents:2
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:GLOPERBA at DailyMed
Drug patent expirations by year for GLOPERBA
Paragraph IV (Patent) Challenges for GLOPERBA
Tradename Dosage Ingredient NDA Submissiondate
GLOPERBA SOLUTION;ORAL colchicine 210942 2020-04-02

US Patents and Regulatory Information for GLOPERBA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avion Pharms GLOPERBA colchicine SOLUTION;ORAL 210942-001 Jan 30, 2019 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Avion Pharms GLOPERBA colchicine SOLUTION;ORAL 210942-001 Jan 30, 2019 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Express Scripts
Merck
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.